0QNV fundamentals
An in-depth look to ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD) operating, investing, and financing activities
0QNV free cash flow for Q4 23 is -619.45 k CHF. For 2023, 0QNV free cash flow was -7.96 M CHF and operating cash flow was -7.95 M CHF.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM